Finance

Lists
300760:SHE
Shenzhen Mindray Bio-Medl Elctrnc Co Ltd
167,30 CN¥
+0,18%
(+0,30) 1D
16-окт., 15:04:34 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300760...
Open
166,50 CN¥
High
170,08 CN¥
Low
165,78 CN¥
Mkt. cap
199,87 млд
Avg. vol.
7,38 млн
Volume
8,09 млн
Dividend
2,53%
Quarterly dividend
1,06 CN¥
Ex-dividend date
2026-ж., 8-сен.
P/E ratio
25,79
52-wk high
233,95 CN¥
52-wk low
130,66 CN¥
EPS
6,49 CN¥
Shares outstanding
1,21 млд
No. of employees
21 миң
Open
166,50 CN¥
High
170,08 CN¥
Low
165,78 CN¥
Mkt. cap
199,87 млд
Avg. vol.
7,38 млн
Volume
8,09 млн
Dividend
2,53%
Quarterly dividend
1,06 CN¥
Ex-dividend date
2026-ж., 8-сен.
P/E ratio
25,79
52-wk high
233,95 CN¥
52-wk low
130,66 CN¥
EPS
6,49 CN¥
Shares outstanding
1,21 млд
No. of employees
21 миң
News stories
From web sources and news partners
Profile
Mindray Bio-Medical Electronics Co., Ltd., simply known as Mindray, is a Chinese multinational health technology company based in Shenzhen, Guangdong. Mindray designs and produces medical equipment and accessories for both human and veterinary use. The company is organized into three key business lines: Patient Monitoring & Life Support, In-Vitro Diagnostic Products, and Medical Imaging Systems. In 2008, Mindray was recognized as China's largest medical device manufacturer. Wikipedia
About Shenzhen Mindray Bio-Medl Elctrnc Co Ltd
CEO-
Employees21,3 миң
Founded1991
Headquarters-
SectorMedical device
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
9,09 млд
7,45 млд
8,35 млд
9,39 млд
Cost of goods sold
3,32 млд
3,70 млд
3,18 млд
3,83 млд
Cost of revenue
3,32 млд
3,70 млд
3,18 млд
3,83 млд
Research and development expenses
828,27 млн
1,14 млд
801,74 млн
767,77 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,68 млд
1,91 млд
1,58 млд
1,63 млд
Operating expense
2,53 млд
3,19 млд
2,39 млд
2,44 млд
Total operating expenses
5,85 млд
6,89 млд
5,57 млд
6,27 млд
Operating income
3,24 млд
563,02 млн
2,78 млд
3,12 млд
Other non operating income
-38,60 млн
13,79 млн
-332,20 млн
288,46 млн
EBT including unusual items
2,98 млд
772,35 млн
2,54 млд
3,01 млд
EBT excluding unusual items
3,16 млд
581,57 млн
2,57 млд
2,97 млд
Income tax expense
403,50 млн
134,78 млн
114,81 млн
394,38 млн
Effective tax rate
13,52%
17,45%
4,52%
13,08%
Other operating expenses
-8,48 млн
90,41 млн
-9,50 млн
47,65 млн
Net income
2,50 млд
565,73 млн
2,33 млд
2,47 млд
Net profit margin
27,51%
7,60%
27,89%
26,26%
Earnings per share
2,07
-
-
-
Interest and investment income
132,38 млн
125,46 млн
124,39 млн
141,61 млн
Interest expense
-6,45 млн
-7,27 млн
-6,07 млн
-5,92 млн
Net interest expenses
125,93 млн
118,19 млн
118,32 млн
135,69 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
3,57 млд
951,35 млн
3,17 млд
3,55 млд
Gain or loss from assets sale
736,57 миң
-10,72 млн
-
9,02 млн
AI content may include mistakes. Learn more
Google колдонмолору